Corcept Therapeutics
CORT
#2368
Rank
$7.33 B
Marketcap
$69.15
Share price
1.26%
Change (1 day)
89.30%
Change (1 year)

Corcept Therapeutics (CORT) - Total assets

Total assets on the balance sheet as of March 2025 : $0.84 Billion USD

According to Corcept Therapeutics 's latest financial reports the company's total assets are $0.84 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Corcept Therapeutics - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$0.84 B35.24%
2023-12-31$0.62 B6.53%
2022-12-31$0.58 B37.68%
2021-12-31$0.42 B-25.88%
2020-12-31$0.57 B38.66%
2019-12-31$0.41 B32.28%
2018-12-31$0.31 B41.33%
2017-12-31$0.22 B220.77%
2016-12-31$68.75 M32.47%
2015-12-31$51.9 M49.88%
2014-12-31$34.63 M-45.1%
2013-12-31$63.07 M-36.39%
2012-12-31$99.16 M148.95%
2011-12-31$39.83 M58.67%
2010-12-31$25.1 M2.42%
2009-12-31$24.51 M23.95%
2008-12-31$19.77 M11.45%
2007-12-31$17.74 M79.2%
2006-12-31$9.9 M-67.16%
2005-12-31$30.15 M-36.88%
2004-12-31$47.77 M305.5%
2003-12-31$11.78 M-45.95%
2002-12-31$21.79 M-10.16%
2001-12-31$24.25 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
$193.67 B 22,780.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$92.42 B 10,819.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$99.94 B 11,707.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
$89.38 B 10,460.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$208.02 B 24,476.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$115.12 B 13,500.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.32 B-61.72%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$0.41 B-51.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$7.14 B 744.35%๐Ÿ‡บ๐Ÿ‡ธ USA